-
Featured Authors
-
Archives
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: International
Legislative Best Practices in Support of Bioscience Economic Development
Despite a difficult economic environment the past couple years, states across the country have found that a number of factors are key to attracting new bioscience industry and helping current bioscience companies thrive in their states. In particular, state initiatives that focus on capital formation, workforce development and a supportive business environment have been key to the success of states that want to grow their bioscience industry In a session titled “Legislative Best Practices in Read More >
Out of Africa: Biomedical Innovation and Expertise
Scientific research holds the key to unlocking creative and effective solutions for alleviating the burden of disease on the world’s populations. Developing countries, such as those in sub-Saharan Africa, are disproportionately encumbered by disease – many of which are endemic only to those geographies. Yet these same regions are a wellspring of innovative and creative ideas that are being used to advance biomedical science and healthcare product development. Research centers within these regions are yet Read More >
Health
Leave a comment
Email This Post
Tags: 2015 BIO International Convention, Africa, BIO International Convention, BIO Ventures for Global Health, biomedical, Biomedical Innovation and Expertise, biopharmaceutical, developing countries, Ghana, health, healthcare, International, Kenya, Mauritius, Nigeria, The sub-Saharan Africa pavilion, Zimbabwe
Tags: 2015 BIO International Convention, Africa, BIO International Convention, BIO Ventures for Global Health, biomedical, Biomedical Innovation and Expertise, biopharmaceutical, developing countries, Ghana, health, healthcare, International, Kenya, Mauritius, Nigeria, The sub-Saharan Africa pavilion, Zimbabwe
BIO Presents at 2014 Biological Weapons Convention Meeting of Experts
Last week marked the annual Biological Weapons Convention (BWC) Meeting of Experts in Geneva. The BWC is a multi-national treaty prohibiting the manufacture of biological weapons, and also contains provisions related to national implementation and multi-national coordination for preparedness and assistance. Each year a Meeting of Experts takes place to discuss ongoing issues related to the implementation of the treaty. This year, for the first time ever, BIO was invited to present on novel technologies Read More >
What International Trade Agreements Have to Do with Innovation
Innovation is not just the life-blood of the biotech industry, it is the very premise of the BIO International Convention. So what is a panel on international trade doing here? Answering this question is the task panel moderator, Richard Bergstrom, Director General, EFPIA gave to participants in the session TTIP: Can US and the EU Lead the Way in Setting New Global Benchmarks for IP, Regulatory and Market Access Issues; and each provided a piece Read More >
Building the Bioeconomy
Leaders across the globe have increasingly begun to target the bioscience industry as an economic engine that provides high wage, high-skilled jobs across a broad range of occupations. During the last decade, this understanding of the economic potential of the industry has led to policies and programs that provide supportive tax environments in capital formation, technology transfer, and funding for a workforce to facilitate research, development, and manufacturing. BIO has just released a first-of-its-kind report Read More >
